With Red light therapy, is it better to utilize in the evening before bed, or upon waking? For more systemic effects, not localized healing.

Sleep isn’t passive recovery it’s a cellular recalibration.And if you're not sleeping deeply, your mitochondria, immune system, and brain aren’t clearing debris, regulating inflammation, or consolidating memory efficiently. Enter: Sleep peptides—not sedatives, but neurobiological modulators that repair signaling patterns upstream of symptoms like fatigue, anxiety, poor REM, and sleep fragmentation. Let’s break down the 3 most compelling tools: 1. DSIP (Delta Sleep-Inducing Peptide) - Primary action: Normalizes sleep architecture and promotes deep non-REM sleep - Mechanism: Reduces corticotropin-releasing hormone (CRH), dampens HPA axis hyperactivity, improves hypothalamic GABA tone - Bonus: Acts on mitochondrial protection and glymphatic clearance - When to use: Difficulty staying asleep, nervous system overdrive, parasympathetic insufficiency 2. Semax - Primary action: Neuroprotective and cognitive-enhancing, especially under stress - Mechanism: Boosts BDNF, modulates dopamine/serotonin, reduces neuroinflammation via NRF2 and antioxidant pathways - Bonus: Promotes resilience under oxidative stress - When to use: Brain fog, mood swings, post-infection fatigue, circadian mismatch 3. Epitalon (Epithalamin analog) - Primary action: Normalizes circadian rhythm via pineal gland restoration - Mechanism: Increases melatonin, reduces oxidative damage, supports telomerase activity, improves pineal peptide signaling - Bonus: Supports SIRT1 and FOXO3a longevity genes - When to use: Chronically poor sleep timing, aging-related rhythm disruption, neuroinflammation Big Picture:These aren’t “knock-you-out” tools like sedatives.They restore signaling fidelity—allowing your body to re-enter deep sleep states and modulate inflammatory and redox pathways during sleep. Want to try them? Stacking depends on your redox state, inflammation load, and circadian integrity. Drop a comment and share your favorite sleep stack.

Every industry has defining moments the ones that separate hype from principle and reveal who’s truly here for the long game. This is one of those moments for ours, and I want to be completely transparent about where we stand. Biomed Industries is the company credited with discovering Bioglutide (NA-931) and developing it as a next-generation GLP-based compound. Our raw materials came from the same supplier Biomed reportedly uses. Recently, serious accusations have surfaced against Biomed claims of fraudulent data, lack of publicly verifiable sequence information, and the absence of a disclosed CAS number or molecular structure. The accuser has raised valid scientific concerns that deserve to be addressed. At the same time, these allegations are new, and Biomed has not yet had the opportunity to publicly respond. That’s why we are pausing not panicking. Even in moments like this, our safeguards remain strong. We can fully document purity through HPLC and LC-MS, confirm sterility and endotoxin levels, and provide verified Certificates of Analysis. However, without a public reference structure or sequence, no lab including ours can confirm 100% molecular identity. We can verify that a compound is clean, sterile, and potent, but we can’t compare it to a molecule that’s never been fully published. To give some context, CB4211 is a great example of how innovation often moves faster than public documentation. This compound, developed for mitochondrial health and metabolic optimization, has been prescribed by physicians and compounded by pharmacies despite its structure, sequence, and CAS never being publicly released. That doesn’t make it ineffective or illegitimate it simply illustrates that, just like Bioglutide, the available data can only go so far. In both cases, these products are sourced, tested, and manufactured to the highest standards, with thorough purity and safety testing but without full structural transparency. That means identity and uniqueness are established through trust, testing, and outcomes rather than public disclosure. For all we know, CB4211 could be a more advanced form or reformulated analog of MOTS-c—or perhaps just a more expensive version under a new label. Until formal sequencing or patent releases are made public, no one can say for sure. This doesn’t discredit its value; it simply reminds us that in early-stage biotech, certainty often trails behind discovery. That’s why rigorous testing, ethical sourcing, and open communication about what is known and what isn’t are so vital.

I hope everyone had a fantastic weekend! We’ve got some exciting updates this week, and I wanted to bring everything together in one post for simplicity. First, big news the Kenetik Pro Buyers Club is officially launching! If you’ve been curious about trying the supplement I personally rely on the most, ketone esters, now’s your chance. I’m thrilled to be able to offer both access and savings. I’ve put together a thread that breaks down everything you’ll need—how to order, how many bottles you’ll likely go through in a month, and pricing details. Next, a quick clarification on the upcoming free webinar. This one is going to pull back the curtain on my own protocol and thought process. You’ll get the full, no-holds-barred breakdown of what I take, why I take it, and how I pair it with training, nutrition, and lifestyle strategies. My goal is to help you see things through a systemic lens so you can craft protocols that are more precise and effective. I want this to be fun, transparent, and useful and I’ll say up front, I’m learning every day right alongside you. Feedback (positive or critical) is always welcome. My plan is to make this a monthly feature, including not just my own protocols but also other people’s, so we can grow as a community of protocol designers together. Finally, a huge thank-you to Kassem Hanson of N1. He’s been an incredible resource for me personally and for our community. I’m currently enrolled in his program design mentorship, and if you want to learn the N1 approach, I can’t recommend their online and in-person seminars enough. They teach customization and critical thinking in a way that resonates whether you’re brand-new or decades into this field. Kassem generously edited the SLU webinar from Saturday, and I’ll be posting the recording soon for anyone who couldn’t attend. I’ll also be sharing the slides here, so if you haven’t received them by email, keep an eye out for the link. Link to webinar reply Thank you all so much for your support and for the energy you bring to this community. Everything we’re building here is possible because of each of you. Please don’t hesitate to reach out if there’s something you’d like to see more of, or if you have suggestions on how I can serve you better. I’m here for you guys!

When I saw this video, sent to me by my fiancée, it really highlighted something important: a lot of health misinformation is packaged so well that it feels convincing especially when it comes from charismatic voices. The problem is, calling something like Hashimoto’s a simple ‘vitamin issue’ ignores the real science and can lead people away from the care they truly need. My goal isn’t to attack anyone, but to help people become more discerning about where they get their health information, and to equip them with the knowledge to take control of their own health with clarity and confidence. I’m sharing the link here so you can see exactly what I’m referring to. After that, I’ll walk through the facts and explain what’s really going on. https://www.instagram.com/reel/DLjIu7TtKmv/?igsh=NXh4dHdrenFiOGo1 The thyroid gland produces mostly T4 (thyroxine) and a much smaller amount of T3 (triiodothyronine). Rough ballpark: ~80–90% T4, ~10–20% T3. So the “20% T3, 80% T4” claim is somewhat misleading. The thyroid doesn’t make that much T3 directly—most circulating T3 is made peripherally, not in the thyroid gland. T4 is a prohormone. It must be converted to T3, the active form, inside tissues like liver, kidney, muscle, and brain. This conversion is catalyzed by deiodinase enzymes (D1, D2, D3), which remove an iodine atom. This is not a methylation reaction. There’s no methyl group transfer involved. The key nutrient cofactors are selenium (for deiodinase activity), iron, zinc, and adequate caloric/redox balance. Giving only T4 (levothyroxine) can be problematic in some individuals because if their deiodinase enzymes are impaired (due to stress, inflammation, nutrient deficiency, illness), they won’t convert enough T4 → T3, leaving them hypothyroid at the tissue level even if their TSH and T4 look “normal.” Giving only T3 can overshoot and create spikes, since T3 has a short half-life. That’s why some clinicians use a combination (like natural desiccated thyroid or compounded T4/T3).